OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2023
(4)
2021
(3)
2015
(2)
2025
(1)
2022
(1)
2018
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Mutators can drive the evolution of multi-resistance to antibiotics.
Not available
S-EPMC10292718
|
biostudies-literature
Cite
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Not available
S-EPMC5819601
|
biostudies-literature
Cite
Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke.
Not available
S-EPMC8055346
|
biostudies-literature
Cite
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Not available
S-EPMC4898313
|
biostudies-literature
Cite
AVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff.
Not available
S-EPMC4676118
|
biostudies-literature
Cite
Exploring threats to generalisability in a large international rehabilitation trial (AVERT).
Not available
S-EPMC4550737
|
biostudies-literature
Cite
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort.
Not available
S-EPMC8791638
|
biostudies-literature
Cite
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19.
Not available
S-EPMC10751594
|
biostudies-literature
Cite
The value of open-source clinical science in pandemic response: lessons from ISARIC.
Not available
S-EPMC8489876
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets